Synthesis and anti-rhinovirus properties of fluoro-substituted flavonoids

Antiviral Chemistry and Chemotherapy

Volumn 16, Issue 4, 2005, Pages 267-276

  Conti, Cinzia ^a   Mastromarino, Paola ^a   Goldoni, Paola ^a   Portalone, Gustavo ^a   Desideri, Nicoletta ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

2 styrylchromones; Anti rhinovirus activity; Flavonoids; X ray crystal structure determination

Indexed keywords

4',6 DICHLOROFLAVAN; 6 FLUORO 3 HYDROXY 2 STYRYLCHROMONE; 6 FLUORO 3 HYDROXYFLAVONE; 6 FLUORO 3 METHOXY 2 STYRYLCHROMONE; 6 FLUORO 3 METHOXYFLAVONE; 6 FLUOROFLAVANONE; 6 FLUOROFLAVONE; 6 FLURO 2 STYRYLCHROMONE; FLAVONE DERIVATIVE; FLAVONOID; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG DESIGN; DRUG POTENCY; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; HUMAN RHINOVIRUS; HUMAN RHINOVIRUS TYPE 14; HUMAN RHINOVIRUS TYPE 1B; IC 50; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; VIROLOGY; VIRUS INFECTION; X RAY CRYSTALLOGRAPHY;

EID: 23744516313     PISSN: 09563202     EISSN: None     Source Type: Journal    
DOI: 10.1177/095632020501600406     Document Type: Article

References (34)

1. Altomare A, Burla MC, Cavalli M, Cascarano G, Giacovazzo C, Gagliardi A, Moliterni AGG, Polidori G & Spagna R (1999) SIR97: a new tool for crystal structure determination and refinement. Journal of Applied Crystallography 32:115-119.
2. Andries K, Dewindt B, Snoeks J, Wouters L, Moereels H, Lewi PJ & Janssen PAJ (1990) Two groups of rhinoviruses revealed by a panel of antiviral compounds present sequence divergence and differential pathogenicity. Journal of Virology 64:1117-1123.
3. Andries K, Dewindt B, Snoeks J, Willebrords R, Stokbroekx R & Lewi, PJ (1991) A comparative test of fifteen compounds against all known rhinovirus serotypes as a basis for a more rational screening program. Antiviral Research 16:213-225.
4. Bauer DJ, Selway JWT, Batchelor JF, Tisdale M, Caldwell JC & Young DAB (1981) 4′,6-Dichloroflavan (BW683C), a new anti-rhinovirus compound. Nature 292:369-370.
5. Chang CT, Chen FC, Chen TS, Hsu KK, Ueng T & Hung M (1961) Synthesis of 6-halogenoflavones and related compounds. Journal of the Chemical Society 3414-3417.
6. Colapietro M, Cappuccio G, Marciante C, Pifferi A, Spagna R & Helliwell JR (1992) The X-ray diffraction station at the Adone wiggler facility: hardware, software and preliminary results. Journal of Applied Crystallography 25:192.
7. Conti C, Mastromarino P, Sgro R & Desideri N (1998) Anti-picornavirus activity of synthetic flavon-3-yl esters. Antiviral Chemistry & Chemotherapy 9:511-515.
8. De Meyer N, Haemers A, Mishra L, Pandey HK, Pieters LAC, Vander Berghe DA & Vlietinck AJ (1991) 4′-Hydroxy-3-methoxyflavones with potent antipicornavirus activity. Journal of Medicinal Chemistry 34:736-746.
9. Desideri N, Conti C, Sestili I, Tomao P, Stein ML & Orsi N (1992) Synthesis and evaluation of anti-rhinovirus 1B activity of oxazolinyl-isoflavans and -3(2H)-isoflavenes. Antiviral Chemistry & Chemotherapy 3:195-202.
10. Desideri N, Conti C, Sestili I, Tomao P, Stein ML & Orsi N (1995) In vitro evaluation of the anti-picornavirus activities of new synthetic flavonoids. Antiviral Chemistry & Chemotherapy 6:298-306.
11. Desideri N, Olivieri S, Stein ML, Sgro R, Orsi N & Conti C (1997) Synthesis and anti-picornavirus activity of homo-isoflavonoids. Antiviral Chemistry & Chemotherapy 8:545-555.
12. Desideri N, Conti C, Sestili I, Mastromarino P & Mastropaolo F (2000) Synthesis and anti-rhinovirus activity of 2-styrylchromones. Antiviral Chemistry & Chemotherapy 11:373-381.
13. Desideri N, Mastromarino P & Conti C (2003) Synthesis and evaluation of antirhinovirus activity of 3-hydroxy and 3-methoxy 2-styrylchromones. Antiviral Chemistry & Chemotherapy 14:195-203.
14. Desiraju GR & Steiner T (Editors) 1999. The Weak Hydrogen Bond in Structural Chemistry and Biology. UK: Oxford University Press.
15. Domenicano A & Hargittai I (Editors) 1992. Accurate Molecular Structures: Their Determination and Importance, p. 457. UK: IUCr and Oxford University Press.
16. Etter MC, MacDonald JC & Bernstein J (1990) Graph-set analysis of hydrogen-bond patterns in organic crystals. Acta Crystallographica B46:256-262.
17. Farrugia LJ (1997) ORTEP-3 for windows - a version of ORTEP-III with a graphical user interface (GUI). Journal of Applied Crystallography 30:565.
18. Fiala M & Kenny GE (1966) Enhancement of rhinovirus plaque formation in human heteroploid cell cultures by magnesium and calcium. Journal of Bacteriology 92:1710-1715.
19. Greenberg SB (2003) Respiratory consequences of rhinovirus infection. Archives of Internal Medicine 163:278-284.
20. Hodek P, Trefil P & Stiborova M (2002) Flavonoids - potent and versatile biologically active compounds interacting with cytochromes P450. Chemico-Biological Interactions 139:1-21.
21. Ibers JA & Hamilton WC (Editors) 1974. International Tables for X-Ray Crystallography, vol. 4; p. 71. Birmingham: Kynoch Press.
22. Jassim SAA & Naji MA (2003) Novel antiviral agents: a medicinal plant perspective. Journal of Applied Microbiology 95:412-427.
23. Levai A, Silva AMS, Cavaliero JAS, Patonay T & Silva VLM (2001) Dimethyldioxirane oxidation of (E,E)-cinnamylideneacetophenones. European Journal of Organic Chemistry 17:3213-3219.
24. Pinto DCGA, Silva AMS, Almeida LMPM, Cavaliero JAS, Levai A & Patonay V (1998) Synthesis of 4-aryl-3-(2-chromonyl)-2-pyrazolines by the 1,3-dipolar cycloaddition of 2-styrlchromones with diazomethane. Journal of Heterocyclic Chemistry 35:217-224.
25. Pinto DCGA, Silva AMS & Cavaliero JAS (2000) A convenient synthesis of new (E)-5-hydroxy-2-styrylchromones by modifications of Baker-Venkataraman method. New Journal of Chemistry 24:85-92.
26. Reddy BP & Krupadanam GLD (1996) The synthesis of 8-allyl-2-styrylchromones by the modified Baker-Venkataraman transformation. Journal of Heterocyclic Chemistry 33:1561-1565.
27. Scudiero DA, Shoemaker RH, Paull KD, Monks A, Tierney S, Nofziger TH, Currens MJ, Seniff D & Boyd MR (1988) Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other tumor cell lines. Cancer Research 48:4827-4833.
28. Semple SJ, Nobbs SF, Pyke SM, Reynolds GD & Flower RLP (1999) Antiviral flavonoid from Pterocaulon sphacelatum, an Australian Aboriginal medicine. Journal of Ethnopharmacology 68:283-288.
29. Sheldrick GM (1997) SHELXL-97, Program for the Refinement of Crystal Structures. Germany: University of Göttingen.
30. Shih SR, Chen SJ, Hakimelahi GH, Liu HJ, Tseng CT & Shia KS (2004) Selective human enterovirus and rhinovirus inhibitors: an overview of capsid-binding and protease-inhibiting molecules. Medicinal Research Reviews 24:449-474.
31. Silva AMS, Pinto DCGA, Travares HR, Cavaliero JAS, Jimeno ML & Elguero J (1998) Novel (E)- and (Z)-2-styrylchromones from (E,E)-2′- hydroxycinnamylidene-acetophenones - xantones from daylight photooxidative cyclization of (E)-2-styrylchromones. European Journal of Organic Chemistry 2031-2038.
32. Silva AMS, Pinto DCGA, Cavaliero JAS, Martinez A, Castro A & Elguero J (2002) An experimental NMR and semi-empirical theoretical study if the conformation of 2-styrylchromones and styryl alkyl or aryl ketones (benzylidene ketones). Journal of Chemical Research (S) 162-164.
33. Tsuchiya Y, Shimizu M, Hiyama Y, Ithoh K, Hashimoto Y, Nakayama M, Horie T & Morita N (1985) Antiviral activity of natural occurring flavonoids in vitro. Chemical & Pharmaceutical Bulletin 33:3881-3886.
34. Van Hoof L, Vanden Berghe DA, Hatfield GM & Vlietinck AJ (1984) Plant antiviral agents; V. 3-Methoxyflavones as potent inhibitors of viral-induced block of cell synthesis. Planta Medica 50:513-517.